Examining air quality in the ICU and its effects on patient outcomes
Association Between Bedside Air Quality in ICU and Complications Including Hospital Acquired Infections and Arrhythmia
This study looks at how air quality in the ICU affects the health and recovery of critically ill patients, especially those with heart problems or the elderly.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | First Affiliated Hospital of Zhejiang University Academic / other |
| Locations | 3 sites (Hangzhou, Zhejiang and 2 other locations) |
| Trial ID | NCT06201754 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between air quality in the Intensive Care Unit (ICU) and clinical outcomes for critically ill patients. It focuses on how air pollution, particularly small particulate matter, may influence cardiovascular health and the risk of hospital-acquired infections. By measuring air quality parameters, the study aims to identify potential adverse effects on patients, especially those with underlying heart conditions or the elderly. The findings could provide insights into improving ICU environments to enhance patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are critically ill patients aged over 18 who are expected to stay in the ICU for at least two days.
Not a fit: Patients who are pregnant or expected to be in the ICU for less than two days may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved air quality management in ICUs, potentially reducing complications and improving outcomes for critically ill patients.
How similar studies have performed: While there is limited research specifically linking air quality in ICUs to patient outcomes, studies have shown that air pollution can adversely affect cardiovascular health, suggesting a potential for meaningful findings in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age greater than 18 years old 2. The subject or their family members fully understand the patient's instructions and sign an informed consent form Exclusion Criteria: 1. Expected ICU hospitalization days are less than 2 days 2. Pregnant women
Where this trial is running
Hangzhou, Zhejiang and 2 other locations
- First Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China (Recruiting)
- The First People's Hospital of Pinghu — Pinghu, China (Not_yet_recruiting)
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University — Taizhou, China (Recruiting)
Study contacts
- Principal investigator: Lingtong Huang — First Affiliated Hospital of Zhejiang University
- Study coordinator: Lingtong Huang
- Email: lingtonghuang@zju.edu.cn
- Phone: 057187216733
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.